<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03274648</url>
  </required_header>
  <id_info>
    <org_study_id>butyrate2017</org_study_id>
    <nct_id>NCT03274648</nct_id>
  </id_info>
  <brief_title>Dietary Interventions and Butyrate Production in Behçet's Patients</brief_title>
  <official_title>Therapeutic Modulation of Butyrate Production in Behçet's Patients: a Dietary Intervention Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero-Universitaria Careggi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria Careggi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A dietary intervention trial will be performed on patients affected by Behçet's syndrome.
      Three different diets will be compared, analyzing their effects on the gut microbiota
      composition, on endogenous butyrate production and on the general symptoms in Behçet's
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A dietary intervention trial will be conducted with the use of three different diets in order
      to compare the effects of these diets on the gut microbiota composition, on endogenous
      butyrate production and on the general symptoms in Behçet's patients.

      The study will be a randomized, open trial designed to test whether a vegetarian diet or an
      habitual diet supplemented with oral butyrate would benefit the butyrate production, the gut
      microbiota composition and the general symptoms of Behçet's patients, compared with the
      habitual diet.

      The study will involve 30 subjects with Behçet syndrome. Patients will be randomly assigned
      to follow a 3-months isocaloric dietary profile with either:

        -  vegetarian diet containing inulin and resistant starch-rich foods, including no meat and
           fish, but containing eggs and dairy products

        -  habitual diet supplemented with 2.4g/day of oral butyrate

        -  habitual diet without supplementation At the baseline visit, subjects will be educated
           about the aims and methods of the clinical trial and will sign their informed consent
           form.

      Anthropometric measurements, body composition, and blood and stool sampling will be obtained
      from each participant at the beginning and at the end of the intervention period. All
      subjects will be examined between 07.00 and 09.30 hours after a 12 h fasting period.

      The following parameters will be analyzed both at the beginning and at the end of the
      intervention period:

        -  Complete blood count

        -  Lipid variables - total cholesterol, low density lipoprotein cholesterol (LDL), high
           density lipoprotein cholesterol (HDL), triglycerides

        -  Glycemic profile - glucose, insulin, glycated hemoglobin (HbA1C), HOMA index

        -  Liver function tests - aspartate aminotransferase (AST), alanine transaminase (ALT),
           gammaglutamyl transferase (GGT), alkaline phosphatase (ALP), albumin, prealbumin

        -  Kidney function tests - serum creatinine, urea, uric acid

        -  Mineral profile - sodium, potassium, magnesium, calcium

        -  Iron metabolism - iron, ferritin

        -  Vitamin profile - vitamin B12, folic acid, vitamin D

        -  Thyroid function - TSH

        -  Inflammatory markers - erythrocyte sedimentation rate (ESR), C-reactive protein (CRP),
           fibrinogen, serum amyloid A (SAA)

        -  Serology for celiac disease - IgA, anti-transglutaminase antibodies (IgA), anti
           endomysium antibodies (IgA)

        -  Circulating levels of inflammatory cytokines

        -  Oxidative stress markers

        -  Gut microbiota composition

        -  Butyrate production

      At the beginning and at the end of the intervention period, participants will be asked to
      complete a questionnaire, which will assess Behçet's symptoms frequency and severity. In
      addition, participants will be contacted by phone to complete a 24-hours recall in order to
      test the adherence to diets they have been assigned to.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2017</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Behçet's will be assigned to one of the following treatments:
vegetarian diet containing inulin and resistant starch-rich foods, including no meat and fish, but containing eggs and dairy products
habitual diet supplemented with 2.4g/day of oral butyrate
habitual diet without supplementation</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of gut microbiota composition</measure>
    <time_frame>0-3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of butyrate production</measure>
    <time_frame>0-3 months</time_frame>
    <description>For the extraction of SCFAs (and butyrate in particular) the method described in Schnorr et al. will be follow&quot; [Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, Basaglia G,et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun 2014;5:3654]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complete blood count</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lipid variables</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score taking into account the levels of: total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), triglycerides</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic profile</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score taking into account the levels of : glucose, insulin, glycated hemoglobin (HbA1C), HOMA index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin profile</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score, taking into account the levels of: vitamin B12, folic acid, vitamin D</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Liver function tests</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score taking into account the levels of: aspartate aminotransferase (AST), alanine transaminase (ALT), gammaglutamyl transferase (GGT), alkaline phosphatase (ALP), albumin, prealbumin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kidney function tests</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score taking into account the levels of : serum creatinine, urea, uric acid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mineral profile</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score taking into account the levels of: sodium, potassium, magnesium, calcium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Iron metabolism</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score taking into account the levels of: iron, ferritin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thyroid function</measure>
    <time_frame>0-3 months</time_frame>
    <description>measurement of TSH levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score taking into account the levels of: erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), fibrinogen, serum amyloid A (SAA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serology for celiac disease</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score taking into account the levels of: IgA, anti-transglutaminase antibodies (IgA), anti endomysium antibodies (IgA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Circulating levels of inflammatory cytokines</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative stress markers</measure>
    <time_frame>0-3 months</time_frame>
    <description>composite score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation Behçet's symptoms frequency and severity</measure>
    <time_frame>0-3 months</time_frame>
    <description>Participants are asked to complete a questionnaire, which will assess Behçet's symptoms frequency and severity.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Beh&amp;#231;Et Disease</condition>
  <arm_group>
    <arm_group_label>vegetarian diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>vegetarian diet containing inulin and resistant starch-rich foods, including no meat and fish, but containing eggs and dairy products</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Habitual diet + oral butyrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>habitual diet supplemented with 2.4g/day of oral butyrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Habitual diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>habitual diet without supplementation</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral butyrate</intervention_name>
    <description>Patients follow the habitual diet supplemented with 2.4g/day of oral butyrate</description>
    <arm_group_label>Habitual diet + oral butyrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vegetarian diet</intervention_name>
    <description>Patients follow a vegetarian diet containing inulin and resistant starch-rich foods, including no meat and fish, but containing eggs and dairy products</description>
    <arm_group_label>vegetarian diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Habitual diet</intervention_name>
    <description>Patients follow the habitual diet</description>
    <arm_group_label>Habitual diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients affected by Behçet's disease

        Exclusion Criteria:

          -  Pregnancy or breastfeeding

          -  Presence of diabetes mellitus

          -  Presence of other immune-mediated diseases

          -  Presence or history of cancer in the last 5 years

          -  Presence of infectious diseases in the last 3 months

          -  No antibiotic therapy in the last 3 months

          -  No vegetarian or vegan diet

          -  No intake of pro- or pre-biotics in the last 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Giacomo Emmi, MD</last_name>
    <phone>0039 055 7947520</phone>
    <email>giacomo.emmi@unifi.it</email>
  </overall_contact>
  <reference>
    <citation>Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behçet's disease: a review. World J Gastroenterol. 2015 Apr 7;21(13):3801-12. doi: 10.3748/wjg.v21.i13.3801. Review.</citation>
    <PMID>25852265</PMID>
  </reference>
  <reference>
    <citation>Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C, Biagi E, Grassi A, Rampelli S, Silvestri E, Centanni M, Cianchi F, Gotti R, Emmi L, Brigidi P, Bizzaro N, De Bellis G, Prisco D, Candela M, D'Elios MM. Behçet's syndrome patients exhibit specific microbiome signature. Autoimmun Rev. 2015 Apr;14(4):269-76. doi: 10.1016/j.autrev.2014.11.009. Epub 2014 Nov 27.</citation>
    <PMID>25435420</PMID>
  </reference>
  <reference>
    <citation>Wong JM. Gut microbiota and cardiometabolic outcomes: influence of dietary patterns and their associated components. Am J Clin Nutr. 2014 Jul;100 Suppl 1:369S-77S. doi: 10.3945/ajcn.113.071639. Epub 2014 Jun 4. Review.</citation>
    <PMID>24898225</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2017</study_first_submitted>
  <study_first_submitted_qc>September 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2017</study_first_posted>
  <last_update_submitted>September 6, 2017</last_update_submitted>
  <last_update_submitted_qc>September 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero-Universitaria Careggi</investigator_affiliation>
    <investigator_full_name>GIACOMO EMMI</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Behcet Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Butyric Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

